MXPA04005226A - 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof. - Google Patents

1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof.

Info

Publication number
MXPA04005226A
MXPA04005226A MXPA04005226A MXPA04005226A MXPA04005226A MX PA04005226 A MXPA04005226 A MX PA04005226A MX PA04005226 A MXPA04005226 A MX PA04005226A MX PA04005226 A MXPA04005226 A MX PA04005226A MX PA04005226 A MXPA04005226 A MX PA04005226A
Authority
MX
Mexico
Prior art keywords
diarylprop
ones
compositions containing
containing same
invention concerns
Prior art date
Application number
MXPA04005226A
Other languages
Spanish (es)
Inventor
Combeau Cecile
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0115739A external-priority patent/FR2833008B1/en
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of MXPA04005226A publication Critical patent/MXPA04005226A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C225/14—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
    • C07C225/16—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/30—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to nitro or nitroso groups
    • C07C279/32—N-nitroguanidines
    • C07C279/36—Substituted N-nitroguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Bending Of Plates, Rods, And Pipes (AREA)
  • Detergent Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The invention concerns 1,3-diarylprop-2-en-1-ones and derivatives, compositions containing same and the use thereof. The invention concerns in particular novel substituted 1,3-diarylprop-2-en-1-ones having a therapeutic activity for use in particular in oncology.
MXPA04005226A 2001-12-05 2002-12-03 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof. MXPA04005226A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0115739A FR2833008B1 (en) 2001-12-05 2001-12-05 1,3-DIARYLPROP-2-IN-1-ONES, COMPOSITIONS CONTAINING THEM, AND USE
FR0214217 2002-11-14
PCT/FR2002/004143 WO2003048106A2 (en) 2001-12-05 2002-12-03 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof

Publications (1)

Publication Number Publication Date
MXPA04005226A true MXPA04005226A (en) 2004-10-11

Family

ID=26213287

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04005226A MXPA04005226A (en) 2001-12-05 2002-12-03 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof.

Country Status (23)

Country Link
EP (1) EP1453790A2 (en)
JP (1) JP2005531494A (en)
KR (1) KR20050044712A (en)
CN (1) CN1612856A (en)
AR (1) AR037479A1 (en)
AU (1) AU2002365644A1 (en)
BR (1) BR0214694A (en)
CA (1) CA2469193A1 (en)
CO (1) CO5580759A2 (en)
EA (1) EA006803B1 (en)
HR (1) HRP20040508A2 (en)
HU (1) HUP0500100A2 (en)
IL (1) IL162223A0 (en)
MA (1) MA27351A1 (en)
MX (1) MXPA04005226A (en)
NZ (1) NZ533224A (en)
PA (1) PA8558501A1 (en)
PE (1) PE20030758A1 (en)
PL (1) PL370676A1 (en)
RS (1) RS47804A (en)
SV (1) SV2003001422A (en)
TW (1) TW200300685A (en)
WO (1) WO2003048106A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2854399B1 (en) * 2003-04-30 2006-11-17 Aventis Pharma Sa 1-ARYL-3- (INDOL-5-YL) -PROP-2-EN-1-ONES, COMPOSITIONS CONTAINING SAME AND USE THEREOF
EP1598353A1 (en) * 2004-05-17 2005-11-23 Boehringer Ingelheim International GmbH Pyrrolobenzimidazolones and their use as antiproliferative agents
WO2017103637A1 (en) 2015-12-18 2017-06-22 Blirt S.A. Diphenylpropane compounds and their cytotoxic activity
CN109467549B (en) * 2018-12-07 2021-02-09 中国药科大学 Quinoline-substituted chalcone compound, preparation method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904697A (en) * 1987-04-09 1990-02-27 Merrell Dow Pharmaceuticals Inc. Controlling the growth of certain tumor tissue with chalcone derivatives
JPH08277242A (en) * 1995-02-08 1996-10-22 Kyowa Hakko Kogyo Co Ltd Propenone derivative
WO1997020814A1 (en) * 1995-12-01 1997-06-12 Kyowa Hakko Kogyo Co., Ltd. Propenone derivatives
WO1999000114A2 (en) * 1997-06-26 1999-01-07 Statens Serum Institut Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones

Also Published As

Publication number Publication date
EA200400764A1 (en) 2004-12-30
BR0214694A (en) 2004-12-14
RS47804A (en) 2006-12-15
CA2469193A1 (en) 2003-06-12
PE20030758A1 (en) 2003-10-07
EA006803B1 (en) 2006-04-28
HUP0500100A2 (en) 2005-05-30
WO2003048106A2 (en) 2003-06-12
HRP20040508A2 (en) 2005-08-31
KR20050044712A (en) 2005-05-12
AR037479A1 (en) 2004-11-10
PL370676A1 (en) 2005-05-30
SV2003001422A (en) 2003-07-10
EP1453790A2 (en) 2004-09-08
NZ533224A (en) 2006-03-31
IL162223A0 (en) 2005-11-20
WO2003048106A3 (en) 2004-03-25
CN1612856A (en) 2005-05-04
JP2005531494A (en) 2005-10-20
MA27351A1 (en) 2005-06-01
CO5580759A2 (en) 2005-11-30
TW200300685A (en) 2003-06-16
AU2002365644A1 (en) 2003-06-17
PA8558501A1 (en) 2003-09-05

Similar Documents

Publication Publication Date Title
MXPA06000247A (en) Substituted tetrahydro-1h.
HUP0401567A3 (en) Novel 4,5-dyhydro-1h-pyrazole derivatives having cb1-antagonistic activity, their use and pharmaceutical compositions containing them
EP0960107A4 (en)
HK1061852A1 (en) 4,5-dihydro-ih-pyrazole derivatives having cb1-antagonistic activity
DE69905170D1 (en) Thiazolopyrimidinderivate
EP1405859A4 (en) Nitrogenous heterocyclic derivative, medicinal composition containing the same, medicinal use thereof and intermediate therefor
JO2410B1 (en) Substituted 6-pyrido-pyrimidines
MY135233A (en) N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
HUP0401638A3 (en) Thiopene-amides, thiazolesulfonamides as antineoplastic agents, and pharmaceutical composition containing the same
DE60216233D1 (en) Carbolinderivate
DE60120712D1 (en) Kallikrein gen
IL166730A0 (en) N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-Ä1,3,4-oxadiazol-2-ylÜphenyl)pyridine-3-sulphonamide as an anticancer agent
HUP0401403A3 (en) 2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them
HUP0400179A3 (en) 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines, their use and pharmaceutical compositions containing them
SE9802937D0 (en) Novel compounds
HUP0303155A3 (en) 2-thio-substituted imidazole derivatives, the use thereof and pharmaceutical compositions containing them
BG101401A (en) Cisaspide extended release oral compositions
AU2002368133A1 (en) 1,3-azole derivative and medicinal composition containing the derivative for treatment for thombosis
IL164887A0 (en) Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
RS47804A (en) 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof
HK1066022A1 (en) Use of 1,1,1,3,3-pentafluorobutan
DE69818492D1 (en) 7-methylthiooxomethyl- und 7-methylthiodioxomethyl-paclitaxele
EP1415983A4 (en) 5-amidino-n-(2-aminophenethyl)-hydroxybenzenesulfonamide derivative, medicinal composition containing the same, and intermediate therefor
AU2002332244A8 (en) Demelanizing agents, beautifying agents, demelanizing compositions and beautifying compositions
HUP0400733A3 (en) New benzylaminopyrimidines, their use and pharmaceutical compositions containing them